Definitive Healthcare (NASDAQ:DH – Get Free Report) and Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings and dividends.
Volatility & Risk
Definitive Healthcare has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500.
Insider & Institutional Ownership
98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 6.9% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Definitive Healthcare | $241.52 million | 0.43 | -$138.93 million | ($1.60) | -0.61 |
| Firefly Neuroscience | $1.14 million | 16.38 | -$19.88 million | ($0.59) | -2.02 |
Firefly Neuroscience has lower revenue, but higher earnings than Definitive Healthcare. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Definitive Healthcare and Firefly Neuroscience, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Definitive Healthcare | 3 | 6 | 0 | 1 | 1.90 |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
Definitive Healthcare presently has a consensus target price of $1.47, indicating a potential upside of 50.15%. Given Definitive Healthcare’s stronger consensus rating and higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than Firefly Neuroscience.
Profitability
This table compares Definitive Healthcare and Firefly Neuroscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Definitive Healthcare | -72.28% | 3.55% | 1.63% |
| Firefly Neuroscience | -506.23% | -90.17% | -72.05% |
Summary
Definitive Healthcare beats Firefly Neuroscience on 11 of the 14 factors compared between the two stocks.
About Definitive Healthcare
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
